Patterns of β-blocker utilization in patients with chronic heart failure: experience from a specialized outpatient heart failure clinic
- 31 January 2004
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 147 (1) , 79-83
- https://doi.org/10.1016/j.ahj.2003.07.022
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Effect of Carvedilol on Survival in Severe Chronic Heart FailureNew England Journal of Medicine, 2001
- Heart failure disease management: A team approachCleveland Clinic Journal of Medicine, 2001
- Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients With Heart FailureJAMA, 2000
- Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) RegistryEuropean Heart Journal, 1999
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)The Lancet, 1999
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- 3-year follow-up of patients randomised in the metoprolol in dilated cardiomyopathy trialThe Lancet, 1998
- Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart diseaseThe Lancet, 1997
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Patterns of Medication Use in Patients With Heart FailureSouthern Medical Journal, 1995